Search
Now showing items 1-8 of 8
Treatment outcomes and their predictive factors in patients withEnterobacter spp., Serratia spp.,Citrobacter spp., Providencia spp., I-indole-positive Proteus spp., andMorganella spp, bloodstream infection
The present study examined the treatment outcomes and factors related to mortality in patients with Enterobacter spp., Serratia spp., Citrobacter spp., Providencia spp., I-indole-positive Proteus spp., and Morganella spp. ...
Clinical outcomes and mortality risk factors among intensive care unit patients with bacteremia at a university hospital
This study aimed to determine the prevalence and antimicrobial susceptibility of causative pathogens associated with 30-day mortality among intensive care unit (ICU) patients with bloodstream infections as well as to analyze ...
Colistin plus sulbactam or fosfomycin against carbapenem-resistant acinetobacter baumannii: improved efficacy or decreased risk of nephrotoxicity?
Background
Acinetobacter baumannii has been recognized as a cause of nosocomial infection. To date, polymyxins, the last-resort therapeutic agents for carbapenem-resistant A. baumannii (CRAB). Thus, the small number of ...
The Synergistic activity and optimizing doses of tigecycline in combination with aminoglycosides against clinical carbapenem-resistant klebsiella pneumoniae isolates
Carbapenem-resistant Enterobacteriaceae (CRE), especially carbapenem-resistant Klebsiella pneumoniae (CRKP), are among the largest pathogenic threats to humans. The available antibiotic treatment options for combating CRKP ...
The Potential use of ceftazidime-avibactam against carbapenem resistant klebsiella pneumoniae clinical isolates harboring different carbapenemase types in a Thai University Hospital
Purpose: MBL and OXA-48 genes in carbapenem-resistant Enterobacterales (CRE) have emerged as a major public health problem worldwide, including Thailand. Due to the lack of susceptibility data and dosing regimens of ...
The First report of a methicillin-resistant staphylococcus aureus isolate harboring type IV SCCmec in Thailand
Methicillin-resistant Staphylococcus aureus (MRSA) is mostly found in Thailand in the hospital as a nosocomial pathogen. This study aimed to report the genetic characterization of a clinical community-acquired MRSA (CA-MRSA) ...
Optimization of linezolid dosing regimens for treatment of vancomycin-resistant enterococci infection
Background: Linezolid, an oxazolidinone antibiotic, is recommended for vancomycin-resistant enterococci (VRE). However, 100% free-drug concentration above the minimum inhibitory concentration (fT>MIC) and an area under the ...
Does vancomycin resistance increase mortality? clinical outcomes and predictive factors for mortality in patients with enterococcus faecium infections
The prevalence of enterococcal infection, especially E. faecium, is increasing, and the issue of the impact of vancomycin resistance on clinical outcomes is controversial. This study aimed to investigate the clinical ...